Journal article 1168 views
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
Ceri Phillips
CNS Drugs, Volume: 18, Issue: 9, Pages: 561 - 574
Swansea University Author: Ceri Phillips
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.2165/00023210-200418090-00002
Abstract
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
| Published in: | CNS Drugs |
|---|---|
| ISSN: | 1172-7047 |
| Published: |
2004
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa1249 |
| first_indexed |
2013-07-23T11:46:42Z |
|---|---|
| last_indexed |
2024-11-14T10:59:47Z |
| id |
cronfa1249 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2023-06-28T16:22:04.7519703</datestamp><bib-version>v2</bib-version><id>1249</id><entry>2011-10-01</entry><title>The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment</title><swanseaauthors><author><sid>932c7a406ab4b6e4a881d422ca03c289</sid><firstname>Ceri</firstname><surname>Phillips</surname><name>Ceri Phillips</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2011-10-01</date><abstract/><type>Journal Article</type><journal>CNS Drugs</journal><volume>18</volume><journalNumber>9</journalNumber><paginationStart>561</paginationStart><paginationEnd>574</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1172-7047</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2004</publishedYear><publishedDate>2004-12-31</publishedDate><doi>10.2165/00023210-200418090-00002</doi><url/><notes>The journal commissioned this research which sought to draw the issues relating to cost-effectiveness of therapies in multiple sclerosis together following considerable discussion and debate in academic/policy arenas. Comprised of a systematic review of the worlds' literature and an assessment of published economic models from across the world.</notes><college>COLLEGE NANME</college><CollegeCode>COLLEGE CODE</CollegeCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-06-28T16:22:04.7519703</lastEdited><Created>2011-10-01T00:00:00.0000000</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Ceri</firstname><surname>Phillips</surname><order>1</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2023-06-28T16:22:04.7519703 v2 1249 2011-10-01 The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment 932c7a406ab4b6e4a881d422ca03c289 Ceri Phillips Ceri Phillips true false 2011-10-01 Journal Article CNS Drugs 18 9 561 574 1172-7047 31 12 2004 2004-12-31 10.2165/00023210-200418090-00002 The journal commissioned this research which sought to draw the issues relating to cost-effectiveness of therapies in multiple sclerosis together following considerable discussion and debate in academic/policy arenas. Comprised of a systematic review of the worlds' literature and an assessment of published economic models from across the world. COLLEGE NANME COLLEGE CODE Swansea University 2023-06-28T16:22:04.7519703 2011-10-01T00:00:00.0000000 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Ceri Phillips 1 |
| title |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment |
| spellingShingle |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment Ceri Phillips |
| title_short |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment |
| title_full |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment |
| title_fullStr |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment |
| title_full_unstemmed |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment |
| title_sort |
The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment |
| author_id_str_mv |
932c7a406ab4b6e4a881d422ca03c289 |
| author_id_fullname_str_mv |
932c7a406ab4b6e4a881d422ca03c289_***_Ceri Phillips |
| author |
Ceri Phillips |
| author2 |
Ceri Phillips |
| format |
Journal article |
| container_title |
CNS Drugs |
| container_volume |
18 |
| container_issue |
9 |
| container_start_page |
561 |
| publishDate |
2004 |
| institution |
Swansea University |
| issn |
1172-7047 |
| doi_str_mv |
10.2165/00023210-200418090-00002 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2004-12-31T03:05:37Z |
| _version_ |
1851088895764070400 |
| score |
11.089386 |